Evidence map›Paper›PMID 14762065›Full record

ArticleGenome research2004

High-resolution analysis of DNA copy number using oligonucleotide microarrays.

Graham R Bignell, Jing Huang, Joel Greshock, Stephen Watt, Adam Butler, Sofie West, Mira Grigorova, Keith W Jones, Wen Wei, Michael R Stratton and 4 more

Abstract readComparative StudyEvaluation StudyValidation Study
In one paragraph

Article in Genome research, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 122 papers.

0numbers the graph read from it
0cells of the map it votes in
122citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

122 citing papers in PubMed.

  1. Review
  2. Article
  3. Cancer Genetics and Clinical Research.Journal of personalized medicine · 2022
    Article
  4. Progress in Methods for Copy Number Variation Profiling.International journal of molecular sciences · 2022
    Review
  5. Article
  6. High-Density RNA Microarrays Synthesized In Situ by Photolithography.Angewandte Chemie (International ed. in English) · 2018
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Cell line modeling for systems medicine in cancers (review).International journal of oncology · 2014
    Review
  16. Article
  17. Article
  18. Genomic approaches to chronic lymphocytic leukemia.Hematology/oncology clinics of North America · 2013
    Review
  19. Article
  20. Overview of DNA microarrays: types, applications, and their future.Current protocols in molecular biology · 2013
    Article

62 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Graham R BignellWellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, UK.
Jing Huang
Joel Greshock
Stephen Watt
Adam Butler
Sofie West
Mira Grigorova
Keith W Jones
Wen Wei
Michael R Stratton
P Andrew Futreal
Barbara Weber
Michael H Shapero
Richard Wooster

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genomic copy number alterations are a feature of many human diseases including cancer. We have evaluated the effectiveness of an oligonucleotide array, originally designed to detect single-nucleotide polymorphisms, to assess DNA copy number. We first showed that fluorescent signal from the oligonucleotide array varies in proportion to both decreases and increases in copy number. Subsequently we applied the system to a series of 20 cancer cell lines. All of the putative homozygous deletions (10) and high-level amplifications (12; putative copy number >4) tested were confirmed by PCR (either qPCR or normal PCR) analysis. Low-level copy number changes for two of the lines under analysis were compared with BAC array CGH; 77% (n = 44) of the autosomal chromosomes used in the comparison showed consistent patterns of LOH (loss of heterozygosity) and low-level amplification. Of the remaining 10 comparisons that were discordant, eight were caused by low SNP densities and failed in both lines. The studies demonstrate that combining the genotype and copy number analyses gives greater insight into the underlying genetic alterations in cancer cells with identification of complex events including loss and reduplication of loci.

Indexed as

Gene DosageCell LineCell Line, TumorDNADNA, NeoplasmGenome, HumanGenotypeHumansLoss of HeterozygosityOligonucleotide Array Sequence AnalysisPolymorphism, Single NucleotideDNADNA, Neoplasm

Identifiers

PMID14762065
PMCPMC327104

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.